Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors

被引：0
|
作者：
Marcell Baranyi
Eszter Molnár
Luca Hegedűs
Zsófia Gábriel
Flóra Gréta Petényi
Fanni Bordás
Violetta Léner
Ivan Ranđelović
Mihály Cserepes
József Tóvári
Balázs Hegedűs
József Tímár
机构：
[1] Semmelweis University,Department of Pathology, Forensic and Insurance Medicine
[2] KINETO Lab Ltd,Department of Thoracic Surgery
[3] University Medicine Essen - Ruhrlandklinik,Department of Anatomy, Cell and Developmental Biology
[4] University Duisburg-Essen,Department of Experimental Pharmacology and the National Tumor Biology Laboratory
[5] Pázmány Péter Catholic University Faculty of Information Technology and Bionics,undefined
[6] Eötvös Loránd University,undefined
[7] National Institute of Oncology,undefined
来源：
British Journal of Cancer | 2024年 / 130卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1059 / 1072
页数：13
相关论文
共 50 条
  • [1] Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors
    Baranyi, Marcell
    Molnar, Eszter
    Hegedus, Luca
    Gabriel, Zsofia
    Petenyi, Flora Greta
    Bordas, Fanni
    Lener, Violetta
    Randelovic, Ivan
    Cserepes, Mihaly
    Tovari, Jozsef
    Hegedus, Balazs
    Timar, Jozsef
    BRITISH JOURNAL OF CANCER, 2024, 130 (06) : 1059 - 1072
  • [2] Farnesyltransferase inhibitors show synergistic anticancer effects in combination with novel KRAS G12C inhibitors
    Timar, Jozsef
    Baranyi, Marcell
    Molnar, Eszter
    Randelovic, Ivan
    Cserepes, Mihaly
    Tovari, Jozsef
    Hegedus, Balazs
    CANCER RESEARCH, 2024, 84 (07)
  • [3] Combination Therapies to Maximize the Impact of KRAS-G12C Inhibitors
    Molina-Arcas, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S97 - S97
  • [4] Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer
    Molina-Arcas, Miriam
    Moore, Christopher
    Rana, Sareena
    van Maldegem, Febe
    Mugarza, Edurne
    Romero-Clavijo, Pablo
    Herbert, Eleanor
    Horswell, Stuart
    Li, Lian-Sheng
    Janes, Matthew R.
    Hancock, David C.
    Downward, Julian
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (510)
  • [5] Development of combination therapies to potentiate the impact of KRAS-G12C inhibitors in lung cancer
    Molina-Arcas, Miriam
    Moore, Christopher
    Rana, Sareena
    Van Maldegem, Febe
    Mugarza, Edurne
    Romero-Clavijo, Pablo
    Horswell, Stuart
    Hancock, David
    Downward, Julian
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [6] Adaptive resistance to KRAS-G12C inhibitors through AXL activation in KRAS-G12C mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Yano, Seiji
    Horinaka, Mano
    Sakai, Toshiyuki
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER SCIENCE, 2024, 115 : 111 - 111
  • [7] Identification of novel peptide inhibitors for the KRas-G12C variant to prevent oncogenic signaling
    Ajmal, Amar
    Ali, Yasir
    Khan, Ajmal
    Wadood, Abdul
    Rehman, Ashfaq Ur
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (18): : 8866 - 8875
  • [8] Discovery of Tetrahydropyridopyrimidines as Irreversible Covalent Inhibitors of KRAS-G12C with In Vivo Activity
    Fell, Jay B.
    Fischer, John P.
    Baer, Brian R.
    Ballard, Joshua
    Blake, James F.
    Bouhana, Karyn
    Brandhuber, Barbara J.
    Briere, David M.
    Burgess, Laurence E.
    Burkard, Michael R.
    Chiang, Harrah
    Chicarelli, Mark J.
    Davidson, Kevin
    Gaudino, John J.
    Hallin, Jill
    Hanson, Lauren
    Hee, Kenneth
    Hicken, Erik J.
    Hinklin, Ronald J.
    Marx, Matthew A.
    Mejia, Macedonio J.
    Olson, Peter
    Savechenkov, Pavel
    Sudhakar, Niranjan
    Tang, Tony P.
    Vigers, Guy P.
    Zecca, Henry
    Christensen, James G.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (12): : 1230 - 1234
  • [9] KRAS-G12C covalent inhibitors: A game changer in the scene of cancer therapies
    Naim, Nabih
    Moukheiber, Sara
    Daou, Samah
    Kourie, Hampig Raphael
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 168
  • [10] Signaling plasticity in pre-clinical models of resistance to KRAS-G12C inhibitors
    Ambrogio, Chiara
    CANCER SCIENCE, 2024, 115 : 1738 - 1738
12345